Currently, there are already some small molecule BET inhibitors with considerable therapeutic effects, such as JQ1 (the first BET inhibitor), OTX015, or ABBV‐744 (phase I for the treatment of AML).118. The gene discussed is DNER; the disease is acute myeloid leukemia.